ArisGlobal Strengths, Domain Expertise, and Key Differentiators
ArisGlobal is a pioneering technology leader redefining how top-performing life sciences organizations accelerate innovation and deliver breakthrough therapies to market. By empowering digital transformation across the product development lifecycle, ArisGlobal enables faster, smarter, and more compliant pathways from discovery to delivery.
ArisGlobal’s LifeSphere platform leverages advanced cognitive and machine-learning technologies to intelligently automate critical stages of the life sciences product lifecycle. Built on over three decades of industry expertise, LifeSphere empowers organizations with real-time insights, enhanced operational efficiency, and streamlined compliance. Its modern, multi-tenant architecture drives cost savings and scalability, enabling life sciences companies to accelerate innovation while optimizing performance across the entire R&D ecosystem.
ArisGlobal Recent Developments
In December 2024, ArisGlobal launched LifeSphere Safety 24.3, featuring innovative Generative AI capabilities, including automated safety narrative generation and LLM-based Dynamic Data Extraction, which boost efficiency and accuracy. Key updates also include an Efficiency Dashboard, EMBASE integration for seamless literature searches, and advanced document tracking. These enhancements further streamline workflows, improve compliance, and deliver measurable value, reinforcing ArisGlobal’s commitment to pioneering AI-driven solutions in the life sciences industry.
In December 2023, ArisGlobal unveiled LifeSphere NavaX, a state-of-the-art cognitive computing engine designed to accelerate the digitization of R&D IT processes. Leveraging cutting-edge technologies such as Large Language Models and Generative AI, this platform represents a significant advancement in research and development capabilities. In 2018, ArisGlobal introduced LifeSphere MultiVigilance, a pioneering platform for individual case study safety report intake. Initially powered by LifeSphere Nava (v1), this platform integrated advanced robotic process automation and cognitive computing technologies, including natural language processing and machine learning, to revolutionize pharmacovigilance operations.
ArisGlobal Mergers and Acquisitions (M&A) Activities
In 2023, ArisGlobal expanded its LifeSphere platform through key acquisitions. In April, the company completed the acquisition of Amplexor Life Sciences, integrating advanced publishing, labeling, and Quality Management System (QMS) capabilities into LifeSphere, thereby enhancing its regulatory, safety, and clinical solutions. Subsequently, in May, ArisGlobal acquired SPORIFY, a solution specializing in data governance and integration for Substances, Products, Organizations, and Referentials (SPOR). This acquisition bolstered LifeSphere's Regulatory Information Management System (RIMS) by enabling proactive data governance and ensuring ISO IDMP compliance, supporting more informed regulatory decisions.
ArisGlobal Customers in ARTW Customer Database
Leveraging a rigorous data-centric research methodology, APPS RUN THE WORLD asks the simple question: Who’s buying ArisGlobal applications and why? And we provide the answers – supported by decades of research – to our clients around the world. Our Customer database has over 100 data fields that detail company usage of ArisGlobal and other enterprise apps by function, customer size, industry, location, implementation status, partner involvement, Line of Business Key Stakeholders and IT decision makers contact details. List of Verified ArisGlobal LifeSphere Platform customers.
ArisGlobal Overview
201 Jones Road, 3rd FL East
Waltham, MA, 2451, United States
1 609-360-4042
https://www.arisglobal.com/
Ownership: - Nordic Capital
Number of Employees: 1700
Functional Markets: Collaboration, Content Management, ERP Services and Operations, PLM, PPM, TRM,
Key Verticals: Life Sciences,
ArisGlobal Key Enterprise and Cloud Applications
ArisGlobal LifeSphere Platform
ArisGlobal Revenues, $M:
| Type/Year | 2023 | 2024 | YoY Growth, % |
|---|---|---|---|
| Total Revenues, $M | Subscribe | Subscribe | Subscribe |
| Enterprise Applications Revenues, $M | Subscribe | Subscribe | Subscribe |
| Cloud Applications Revenues, $M | Subscribe | Subscribe | Subscribe |
* Enterprise Applications Revenues = License + Support & Maintenance + SaaS
** All revenue figures are estimates based on public records, Cloud and Non-Cloud business models in Apps Run The World's vendor database, and annual survey results including vendor feedback.
ArisGlobal Revenue Breakdown By Type, $M:
ArisGlobal Enterprise Applications Revenues By Functional Markets, $M:
ArisGlobal Enterprise Applications Revenues By Verticals, $M:
ArisGlobal Revenues By Region, $M
| Region | % of Total Revenues | 2024 Total Revenues, $M | 2024 Enterprise Applications Revenues, $M | 2024 Cloud Applications Revenues, $M |
|---|---|---|---|---|
| Americas | Subscribe | Subscribe | Subscribe | Subscribe |
| EMEA | Subscribe | Subscribe | Subscribe | Subscribe |
| APAC | Subscribe | Subscribe | Subscribe | Subscribe |
| Total | Subscribe | Subscribe | Subscribe | Subscribe |
ArisGlobal Direct vs Indirect sales
| Type | Direct Sales | Indirect Sales | Total |
|---|---|---|---|
| Type % | Subscribe | Subscribe | Subscribe |
| Revenues, $M | Subscribe | Subscribe | Subscribe |
ArisGlobal Customers - Breakdown by Geo, Size, Vertical and Product
List of Verified ArisGlobal Customers
No. of ArisGlobal Customers: 220
No. of ArisGlobal Enterprise Applications Customers: 220
No. of ArisGlobal Cloud Customers: x
No. of ArisGlobal Cloud Subscribers: x
ArisGlobal empowers over 220 top-tier life sciences organizations with intelligent, data-driven technology solutions that streamline regulatory workflows, reduce compliance complexities, and accelerate time-to-market. By delivering measurable gains in operational agility and risk mitigation, ArisGlobal helps its clients drive innovation with precision and confidence. With a trusted roster of global leaders—including AstraZeneca, Merz Pharmaceuticals, the China FDA Center for Drug Evaluation, and others—ArisGlobal’s platform stands as a proven catalyst for advancing regulatory, safety, and clinical performance in a highly competitive and evolving industry.
ArisGlobal Market Opportunities, M&A and Geo Expansions
In January 2025, ArisGlobal marked a transformative milestone, highlighting 2024 as a breakthrough year of accelerated customer acquisition, market expansion, and next-gen product innovation—solidifying a strong growth trajectory for 2025. Fueled by a 40% year-over-year increase in APAC customer adoption and 11 new top-tier pharma clients, the company also celebrated 91 customer expansions, reinforcing the value and ROI of its LifeSphere® Safety and Regulatory platforms. With 57 successful go-lives—including implementations for three of the world’s top 10 pharma companies—and a 23% surge in global deployments, ArisGlobal demonstrated unmatched executional excellence. The launch of its ‘Most Valued Customer’ program and rapid adoption of LifeSphere NavaX underscore growing market confidence and the company’s strategic commitment to customer-centric innovation, positioning ArisGlobal as a pivotal growth partner in the evolving life sciences landscape.
ArisGlobal Risks and Challenges
ArisGlobal recognizes that, despite its strong market position, there are key risks that could impact future performance. The company is aware of growing competition from AI-powered regulatory platforms, which could challenge its technological edge. Evolving global compliance standards also require continuous updates to product capabilities, adding pressure on R&D and implementation cycles. Furthermore, ArisGlobal acknowledges the risk of revenue concentration, given its reliance on major pharmaceutical clients. Expanding into new markets brings operational complexity, and with increasing volumes of sensitive regulatory data, cybersecurity and data privacy remain top priorities. To mitigate these risks, ArisGlobal remains committed to innovation, strengthening customer support infrastructure, and expanding its global delivery capabilities.
ArisGlobal Ecosystem, Partners, Resellers and SI
ArisGlobal has formed a strategic partnership with Celegence to deliver a powerful, analytics-driven transformation in regulatory operations for the life sciences industry. By integrating ArisGlobal’s cutting-edge LifeSphere® technology with Celegence’s regulatory expertise, the collaboration enables faster, more compliant implementations, reduces operational complexity, and supports intelligent data governance across pharma, medical devices, and cosmetics. This alliance is designed to maximize efficiency, accelerate regulatory submissions, and provide real-time visibility into workflows—offering measurable ROI for organizations navigating increasingly complex compliance demands. Together, ArisGlobal and Celegence present a future-ready, end-to-end solution that empowers life sciences companies to drive digital innovation, achieve operational excellence, and bring therapies to market with greater speed and confidence.
Research Methodology
Data used in research reports are derived from publicly available documents, continuous surveys of applications vendors, customers, resellers, Independent Software Vendors, systems integrators and other verifiable sources.
Vendor shares and market forecast results are based on a combination of existing databases as well as demand side and supply side research conducted throughout the year with validation from vendors, customers, channel partners and documentations such as earnings releases and 10Q and 10K filings, vertical industry studies, regional and country-level statistics from public and private institutions(i.e. colleges, universities, government agencies and trade associations).
For additional information on our methodologies, here's the link:
https://www.appsruntheworld.com/About Ushttps://www.appsruntheworld.com/taxonomy
https://www.appsruntheworld.com/FAQ
